August 29, 2022: FDA warns “Tramadol US” to stop selling controlled, unapproved drugs to U.S. residents - Partnership for Safe Medicines
FDA warns 'Tramadol US' to cease selling controlled, unapproved drugs to U.S. residents.
Aforeworn detected this change in the Pharmaceutical Manufacturing (FDA/DEA) space on September 2, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated High urgency. All pharmaceutical manufacturers and distributors involved in the sale of controlled substances. should confirm how it applies to their specific situation before acting. There is a time constraint attached: Immediate cessation required upon receipt of the warning.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Pharmaceutical Manufacturing (FDA/DEA) continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
The FDA has issued a warning to stop the sale of controlled, unapproved drugs to U.S. residents.
Who it affects
All pharmaceutical manufacturers and distributors involved in the sale of controlled substances.
What you must do
Immediately halt the sale of any controlled substances that are not FDA-approved.
Deadline
Immediate cessation required upon receipt of the warning.
Never miss a change like this again
Aforeworn watches Pharmaceutical Manufacturing (FDA/DEA) around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Pharmaceutical Manufacturing (FDA/DEA)
- FDA OKs pharmacies to provide abortion pill, but in Wisconsin things are more complicated - wpr.org
- FDA Issues New Guidance on Current Good Manufacturing Practices for Drugs - Arnold & Porter
- A Texas Federal Court Sides with Laboratories, But There May Be Unintended Consequences for FDA - mintz.com
- GLP-1 Fraud: Asheville Wellness Owner Charged With Distributing Unlicensed Tirzepatide - techtimes.com
- Jackson bill to lower cost of prescription drugs becomes law - mainesenate.org